See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2017_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 103,007,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 177,630,000 |
| 2 | PropertyPlantAndEquipmentNet | 10,998,000 |
| 3 | remainder_Assets | 31,229,000 |
| 4 | LiabilitiesCurrent | 31,948,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 121,268,000 |
| 7 | CostOfGoodsAndServicesSold | 96,793,485 |
| 8 | SellingGeneralAndAdministrativeExpense | 33,134,499 |
| 9 | ResearchAndDevelopmentExpense | 2,899,081 |
| 10 | remainder_Expenses | 64,406,408 |
| 11 | remainder_Revenues | 389,743,550 |
| 12 | remainder_NetIncome | -11,370,539 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 322,864,000 |
| 1 | Liabilities | 153,216,000 |
| 2 | Expenses | 197,233,473 |
| 3 | Revenues | 389,743,550 |
| 4 | StockholdersEquity | 169,648,000 |
| 5 | NetIncome | 181,139,538 |
| 6 | ComprehensiveNetIncome | 181,139,538 |
| 7 | BaseVar | 537,213,781 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.31 |
| 9 | EconomicCapitalRatio | 3.23 |
Edgar->Model Mapping
Feature Distribution
Change over Time
